Two competing proteins affect the chronic inflammation of the nervous system following viral infection

Figure 1: Inflammation of the central nervous system following a viral infection can lead to fatigue and depression depending on the competing activity of two cytokine proteins. Credit: imtmphoto/iStock/Thinkstock

Fatigue and depression are common during and after viral infection, and in some cases can become chronic long-term ailments. Fever and inflammation associated with viral infections are triggered by the release of proinflammatory proteins called cytokines. These proteins can also trigger persistent inflammation of the central nervous system, or neuroinflammation, which is thought to be a key factor in the onset of viral-related depression and fatigue. The exact molecular mechanisms involved, however, are not fully understood.

Yosky Kataoka, Masanori Yamato and colleagues from the RIKEN Center for Life Science Technologies have now uncovered the roles of two cytokines, interleukin 1 beta (IL-1β) and its receptor antagonist IL-1ra, in triggering and controlling neuroinflammation in rats.

When faced with viral infection, the body's immune system responds by releasing cytokines. Overexpression of specific cytokines known as interferon alpha (IFN-α) in the brain can trigger long-term neuroinflammation. Previous research has shown that injecting animals with a synthetic double-stranded RNA called poly I:C, which mimics the activity of a virus in the body, induces a decrease in behavioral activity caused by IFN-α overexpression in the brain. Kataoka's team conducted a series of experiments involving poly I:C injection in rats, and found that levels of spontaneous behavior in the rats fell significantly after injection, yet showed signs of recovery after a week.

"We wanted to expand on previous studies and work out which mechanisms tip the balance towards more chronic problems," says Kataoka. "We focused on two main , IL-1β, and its competing molecule IL-1ra."

By injecting IL-1β into the rat brain, the team generated the same dip in spontaneous activity as observed following poly I:C injection, showing that IL-1β was responsible for inducing the production of IFN-α and therefore influencing levels of neuroinflammation. "We also noted that IL-1ra is a functional regulator of IL-1β," mentions Kataoka.

The researchers demonstrated that blocking the efficacy of IL-1ra in the brain delayed the rats' recovery still further. Infusion of IL-1ra into the brains of rats injected with poly I:C, on the other hand, arrested the depressive behavior.

"These results indicate that IL-1ra has an important role in preventing neuroinflammation entering a chronic state," explains Kataoka. "Maintaining a careful balance in the production of IL-1β and IL-1ra is therefore crucial for healthy function."

More information: Yamato, M., Tamura, Y., Eguchi, A., Kume, S., Miyashige, Y., Nakano, M., Watanabe, Y. & Kataoka, Y. "Brain interleukin-1β and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats." PLoS ONE 9, e90950 (2014).
DOI: 10.1371/journal.pone.0090950

add to favorites email to friend print save as pdf

Related Stories

Anti-inflammatory chemical could prevent stroke damage

Dec 05, 2011

(Medical Xpress) -- Drugs that block inflammation in the brain could help patients who have a stroke or a brain haemorrhage, Manchester scientists said today (5 December) at the British Society for Immunology Congress in ...

Recommended for you

A better biomonitor for children with asthma

Dec 10, 2014

For the firefighters and rescue workers conducting the rescue and cleanup operations at Ground Zero from September 2001 to May 2002, exposure to hazardous airborne particles led to a disturbing "WTC cough"—obstructed ...

New insight into risk of Ankylosing Spondylitis

Dec 09, 2014

Scientists at the University of Southampton have discovered variations in an enzyme belonging to the immune system that leaves individuals susceptible to Ankylosing Spondylitis.

Novel approach to treating asthma: Neutralize the trigger

Dec 03, 2014

Current asthma treatments can alleviate wheezing, coughing and other symptoms felt by millions of Americans every year, but they don't get to the root cause of the condition. Now, for the first time, scientists ...

Inflammatory discovery sheds new light on skin disease

Dec 02, 2014

Inflammatory skin diseases such as psoriasis may result from abnormal activation of cell death pathways previously believed to suppress inflammation, a surprise finding that could help to develop new ways ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.